Gemini Therapeutics
unknown
unknown
Stage
1
Investors
About
Gemini Therapeutics is a precision medicine company developing new therapies for dry age-related macular degeneration (dry AMD).
Explore Gemini Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.